Lifileucel

So as Dr.

Banks mentioned, you know, Ivance, uh, developed the Lifileucel or Amtagvi therapy, which is FDA approved.

And so as patients are now being treated across the country at authorized treatment centers, there's a lot of data being generated both in-house on the manufacturing side within Ivance, but also at the clinical data at the centers that are treating these patients.

And so we're really interested in that question.

I think there's a lot of data that has yet to be analyzed and, and I think it involves cooperative agreements between our industry partners and our academic partners.

As, as any of us w- work in this space know, you know, data transfer agreements are, are not a simple feat between both institutions or industry.

But I think as we're able to analyze those data-- And the nice thing about Amtagvi or Lifileucel is that the manufacturing is consistent, right? Individual institutions have a lot of their own manufacturing, um, practices for their IITs, but for Lifileucel it's consistent.

And so w- I think we can really answer that question.